Clinical trial · Observational
The Exceptional Patient in Cancer Care
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objectives of this study is to conduct a multicenter, dual country (United States and Israel), study examining the experience of patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state. The primary aim of the study is to develop a detailed description of patients' experience of an exceptional disease course. The secondary aim is to define the content domain for assessment and measurement of exceptional disease course in patients with cancer and identify lessons learned from these exceptional patients that can be a base for future studies to benefit others.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interview | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients diagnosed with cancer
- interventionNames
- Behavioral: Interview
Primary outcomes (1)
- measure
- Qualitative Data Collection: Patients' Experience of Exceptional Disease Course
- timeFrame
- 2 Years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18 years of age or older 2. Ability to speak and read English with patients residing in the US, ability to speak and read Hebrew with patients residing in Israel. 3. Diagnosis of cancer confirmed by pathology. 4. Exceptional disease course as identified by patients' physician, in terms of survival and unusual disease course that is appropriately medically documented. 5. Consent to participate in this study. Exclusion Criteria: 1. Inability to understand the intent of the study. 2. Medical condition that would preclude participation in an interview session lasting 30-45 minutes. 3. Diagnosis of active psychosis or severe cognitive impairment confirmed by the patient's attending physician.
References
Publications (1)
- RESULTFrenkel M, Ari SL, Engebretson J, Peterson N, Maimon Y, Cohen L, Kacen L. Activism among exceptional patients with cancer. Support Care Cancer. 2011 Aug;19(8):1125-32. doi: 10.1007/s00520-010-0918-6. Epub 2010 May 29. PMID 20512358